Sex, ethnicity, and antipsychotic medication use in patients with psychosis

Schizophrenia Research

Volumn 66, Issue 2-3, 2004, Pages 169-175

  Arnold, Lesley M ^a   Strakowski, Stephen M ^a   Schwiers, Michael L ^b   Amicone, Jennifer ^a   Fleck, David E ^a   Corey, Kimberly B ^a   Farrow, Jenni E ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Antipsychotic; Ethnicity; Psychosis; Race; Sex

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; AFRICAN AMERICAN; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DRUG DOSE REGIMEN; DRUG INDICATION; DRUG MEGADOSE; ETHNIC DIFFERENCE; ETHNOLOGY; EVALUATION; FEMALE; HEALTH STATISTICS; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOSIS; SEX DIFFERENCE; SOCIAL ASPECT;

EID: 0348047432     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(03)00102-6     Document Type: Article

References (24)

1. Andreasen N.C. The Scale for the Assessment of Positive Symptoms (SAPS). 1984;University of Iowa, Iowa City, IA.
2. Arnold, L.M., Keck Jr., P.E., Collins, J., Wilson, R., Fleck, D.E., Corey, K.B., Amicone, J., Adebimpe, V.R., Strakowski, S.M., in press. Ethnicity and first-rank symptoms in patients with psychosis.
3. Casey D.E. Barriers to progress - the impact of tolerability problems. Int. Clin. Psychopharmacol. 16:2001;S15-S19.
4. Citrome L., Levine J., Allingham B. Utilization of depot neuroleptic medication in psychiatric inpatients. Psychopharmacol. Bull. 32:1996;321-326.
5. Davis J.M., Matalon L., Watanabe M.D., Blake L., Metalon L. Depot antipsychotic drugs. Place in therapy. Drugs. 47:1994;741-743.
6. Fleck D.E., Hendricks W.L., DelBello M.P., Strakowski S.M. Differential prescription of maintenance antipsychotics to African-American and white patients with new-onset bipolar disorder. J. Clin. Psychiatry. 63:2002;658-664.
7. Glazer W.M., Kane J.M. Depot neuroleptic therapy: an underutilized treatment option. J. Clin. Psychiatry. 53:1992;426-433.
8. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. 23:1960;56-61.
9. Inderbitzin L.B., Lewine R.R., Gloersen B., Rosen P.B., McDonald S.C., Vidanagama B.P. Fluphenazine decanoate: a clinical problem? Am. J. Psychiatry. 146:1989;88-91.
10. Kuno E., Rothbard A.B. Racial disparities in antipsychotic prescription patterns for patients with schizophrenia. Am. J. Psychiatry. 159:2002;567-572.
11. Lehman A.F., Steinwachs D.M. Patterns of usual care for schizophrenia: initial results from the schizophrenia patient outcomes research team (PORT) client survey. Schizophr. Bull. 24:1998;11-20.
12. Lehman A.F., Steinwachs D.M. At issue: translating research into practice: the Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations. Schizophr. Bull. 24:1998;1-10.
13. Pies R.W. Handbook of Essential Psychopharmacology. 1st ed. 1998;123 American Psychiatric Press, Washington, DC.
14. Price N., Glazer W., Morgenstern H. Demographic predictors of the use of injectable versus oral antipsychotic medications in outpatients. Am. J. Psychiatry. 142:1985;1491-1492.
15. Ruiz P., Varner R.V., Small D.R., Johnson B.A. Ethnic differences in the neuroleptic treatment of schizophrenia. Psychiatr. Q. 70:1999;163-172.
16. Schatzberg A.F., Cole J.O., DeBattista C. Manual of Clinical Psychopharmacology. 3rd ed. 1997;113-180 American Psychiatric Press, Washington, DC.
17. Strakowski S.M., Shelton R.C., Kolbrener M.L. The effects of race and comorbidity on clinical diagnosis in patients with psychosis. J. Clin. Psychiatry. 54:1993;96-102.
18. Strakowski S.M., Flaum F., Amador X., Bracha H.S., Pandurangi A.K., Robinson D., Tohen M. Racial differences in the diagnosis of psychosis. Schizophr. Res. 21:1996;117-124.
19. Strakowski S.M., McElroy S.L., Keck P.E. Jr., West S.A. Racial influence on diagnosis in psychotic mania. J. Affect. Disord. 39:1996;157-162.
20. Strakowski, S.M., Keck Jr., P.E., Arnold, L.M., Collins, J., Wilson, R.M., Fleck, D.E., Corey, K.B., Amicone, J., Adebimpe, V.R., in press. Ethnicity and diagnosis in patients with affective psychosis.
21. Valenstein M., Copeland L.A., Owen R., Blow F.C., Visnic S. Adherence assessments and the use of depot antipsychotics in patients with schizophrenia. J. Clin. Psychiatry. 62:2001;545-551.
22. Walkup J.T., McAlpine D.D., Olfson M., Labay L.E., Boyer C., Hansell S. Patients with schizophrenia at risk for excessive antipsychotic dosing. J. Clin. Psychiatry. 61:2000;344-348.
23. Wang P.S., West J.C., Tanielian T., Pincas H.A. Recent patterns and predictors of antipsychotic medication regimens used to treat schizophrenia and other psychotic disorders. Schizophr. Bull. 26:2000;451-457.
24. Young R.C., Biggs J.T., Ziegler V.E., Mayer D.A. A rating scale for mania: reliability, validity and sensitivity. Br. J. Psychiatry. 133:1978;429-435.